Alpha Profiles · Company Profile

Dyne Therapeutics, Inc.

Canonical company identity and public leadership record.

https://registry.alpha.ac/companies/dyne-therapeutics-inc

Entity: Public listing published
Primary listing: NASDAQ: DYN
Verification: Partially verified
Last reviewed: 2026-09-15T20:38:06.971658+00:00

Overview

Alpha's canonical identity and public leadership record for Dyne Therapeutics, Inc..

Canonical AEGIS identity graph

Executive leadership

Current, confirmed roles are shown only when both the person Profile and supporting source record satisfy the public projection boundary. A missing role is not evidence that it does not exist.

Executive team

7 public records

Douglas Kerr

Chief Medical Officer

State: confirmed
Effective: Date not stated
Confidence: 95%
Evidence: SEC DEF 14A 0001193125-26-173655Apr 23, 2026

Erick Lucera

Chief Financial Officer and Treasurer

State: confirmed
Effective: Date not stated
Confidence: 95%
Evidence: SEC DEF 14A 0001193125-26-173655Apr 23, 2026

Jeremy K. Cox

Chief Executive Officer, President and Director

State: confirmed
Effective: From Apr 23, 2026
Confidence: 94%
Evidence: DYN DEF 14A executive officersApr 23, 2026

Johanna Friedl-Naderer

Chief Commercial Officer

State: confirmed
Effective: Date not stated
Confidence: 95%
Evidence: SEC DEF 14A 0001193125-26-173655Apr 23, 2026

John G. Cox

Chief Executive Officer and President

State: confirmed
Effective: Date not stated
Confidence: 95%
Evidence: SEC DEF 14A 0001193125-26-173655Apr 23, 2026

Oxana Beskrovnaya

Chief Innovation Officer

State: confirmed
Effective: From Apr 23, 2026
Confidence: 94%
Evidence: DYN DEF 14A executive officersApr 23, 2026

Richard Scalzo

Senior Vice President, Head of Finance and Administration

State: confirmed
Effective: From Apr 23, 2026
Confidence: 94%
Evidence: DYN DEF 14A executive officersApr 23, 2026

Governance leadership

Boards & Committees

Board and committee assignments appear only when the canonical public projection retains a current role and supporting source. Unpublished records are not interpreted as absence.

Record as of Sep 15, 2026. Chair, executive office, Lead Independent Director and committee appointments retain their separate source roles. A complete board composition denominator and committee charters are not established by a partial roster.